TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Enovis Surgical Sweden AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
2,366
|
2,516
|
2,008 |
| Financial expenses |
61
|
56
|
129 |
| Earnings before taxes |
-82
|
45
|
60 |
| EBITDA |
233
|
443
|
555 |
| Total assets |
2,147
|
2,872
|
2,493 |
| Current assets |
1,631
|
2,217
|
1,752 |
| Current liabilities |
1,033
|
1,194
|
870 |
| Equity capital |
110
|
199
|
151 |
| - share capital |
9
|
9
|
9 |
| Employees (average) |
0
|
0
|
0 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
5.1%
|
6.9%
|
6.1% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
-3.5%
|
1.8%
|
3.0% |
| Return on assets (ROA) |
-1.0%
|
3.5%
|
7.6% |
| Current ratio |
157.9%
|
185.7%
|
201.4% |
| Return on equity (ROE) |
-74.5%
|
22.6%
|
39.7% |
| Change turnover |
-65
|
502
|
502 |
| Change turnover % |
-3%
|
25%
|
33% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.